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Abstract
Fatty acid (FA)-derived lipid products generated by cytochrome P450 (CYP),
lipoxygenase (LOX), and cyclo-oxygenase (COX) influence cardiovascular
function. However, plasma measurements invariably ignore 40% of the blood
specimen, namely the erythrocytes. These red blood cells (RBCs) represent a
cell mass of about 3 kg. RBCs are a potential reservoir for epoxy fatty acids,
which on release could regulate vascular capacity. We tested the hypothesis
that maximal physical activity would influence the epoxy fatty acid status in
RBCs. We used a standardized maximal treadmill exercise according to Bruce
to ensure a robust hemodynamic and metabolic response. Central hemody-
namic monitoring was performed using blood pressure and heart rate mea-
surements and maximal workload was assessed in metabolic equivalents
(METs). We used tandem mass spectrometry (LC-MS/MS) to measure epox-
ides derived from CYP monooxygenase, as well as metabolites derived from
LOX, COX, and CYP hydroxylase pathways. Venous blood was obtained for
RBC lipidomics. With the incremental exercise test, increases in the levels of
various CYP epoxy-mediators in RBCs, including epoxyoctadecenoic acids
(9,10-EpOME, 12,13-EpOME), epoxyeicosatrienoic acids (5,6-EET, 11,12-EET,
14,15-EET), and epoxydocosapentaenoic acids (16,17-EDP, 19,20-EDP)
occurred, as heart rate, systolic blood pressure, and plasma lactate concentra-
tions increased. Maximal (13.5 METs) exercise intensity had no effect on diols
and various LOX, COX, and hydroxylase mediators. Our findings suggest that
CYP epoxy-metabolites could contribute to the cardiovascular response to
maximal exercise.
Introduction
Optimal exercise performance requires an integrated
organ system response. The entire cardiovascular system,
pulmonary, systemic circulations enable increased gas
exchange and oxygen availability to exercising muscles.
The cardiovascular adaptations to maximal exercise
include an increase in cardiac output resulting from an
increased heart rate and to a lesser degree stroke volume,
as well as a widening of the arteriovenous oxygen
difference (Weiner, 1983). The rate of skeletal muscle
blood flow degree and degree of oxygen consumption are
increased (Weiner, 1983). The net effect of acute systemic
hypoxia in quiescent skeletal muscle is vasodilation that
occurs despite significant reflex increases in muscle sym-
pathetic nerve activity. This vasodilation increases tissue
perfusion and oxygen delivery to maintain tissue oxygen
consumption (Dinenno, 2016). Although several mecha-
nisms may be involved, there is evidence for local
vasodilatory control mechanisms involving nitric oxide
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(NO) and prostaglandins (PGs) (Dinenno, 2016). When
the stimulus is exacerbated via combined (sub)maximal
exercise and systemic hypoxia to cause further red blood
cell (RBC) deoxygenation, local vasodilation augments
skeletal muscle blood flow. ATP release and nitrite reduc-
tion to NO have been shown to be involved in regulating
this response (Dinenno, 2016; Zhang et al., 2018; Pernow
et al., 2019).
PGs and other eicosanoids, such thromboxanes (TXs),
leukotrienes (LTs), epoxides, and hydro(peroxy) fatty
acids (or oxylipins) are lipid peroxidation products of 20-
carbon (eicosa-) polyunsaturated fatty acids (PUFA).
These products are generated by three separate enzyme
families, namely cyclooxygenase (COX), lipoxygenase
(LOX), and cytochrome P450 (CYP) expoygenases. These
pathways catalyse lipid peroxidation in a highly regulated
manner generating stereo and regio-specific products
(Fig. 1). Their expression is highly tissue-localized and
varies with inflammatory activation state. Primary prod-
ucts of COX, LOX, and CYP are metabolized, depending
on cell type, into secondary eicosanoids and their
metabolites, some of which are also potently bioactive
(Fig. 1). The major metabolic pathways of PUFA epoxides
are incorporation into phospholipids and hydrolysis to
the corresponding PUFA diols by soluble epoxide hydro-
lase (sEH) (Spector and Kim, 2015). In a number of vas-
cular beds, CYP-derived epoxyeicosatrienoic acids (EETs)
and other epoxides, such as 17,18-epoxyeicosatetraenoic
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Figure 1. Short-term maximal exercise associated with increased vasopressor and shear stress, red blood cell (RBC)-endothelial interactions and
tissue hypoxia affecting the content of epoxy-metabolites in RBCs. The proposal illustrates cytochrome P450 epoxygenase (CYP) and 12- and
15-lipoxygenase (LOX)/ CYP omega-hydroxylase pathways. Linoleic (LA), arachidonic (AA), eicosapentaenoic (EPA), and docosahexaenoic acids
(DHA) are converted to epoxyoctadecenoic acids (EpOMEs, e.g., 9,10-EpOME), epoxyeicosatrienoic acid (EETs, e.g., 5,6-EET, 11,12-EET),
epoxyeicosatetraenoic acids (EEQs) and epoxydocosapentaenoic acids (EDPs, e.g., 19,20-EDP) by CYP, respectively. EpOMEs, EETs, EEQs and
EDPs are metabolized to dihydroxyctadecenoic acids (DiHOMEs, e.g., 9,10-DiHOME), dihydroxyeicosatrienoic acids (DHETs, e.g., 5,6-DHET),
dihydroxyeicosatetraenoic acids (DiHETEs) and dihydroxydocosapentaenoic acids (DiHDPAs, e.g., 19,20-DiHDPA), respectively, by the soluble
epoxide hydrolase (sEH) enzyme. LA, AA, EPA, and DHA are converted to hydroperoxylinoleic acids (HpODEs), hydroxyoctadecadienoic acids
(HODEs), hydroxydocosahexaenoic acids (HDHAs), hydroperoxyeicosatetraenoic acids (HPETEs) and hydroxyeicosatetraenoic acids (HETEs) by
LOX, CYP omega/(omega-1)-hydroxylase and peroxidase pathways. The metabolites measured within these pathways track the changes
observed in LA, AA, EPA, and DHA, respectively. Arrows demarcate metabolic pathways evaluated.
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acid (17,18-EEQ), can function as endothelium-derived
hyperpolarizing factors (EDHF) that contribute to vasodi-
lation (Hu and Kim, 1993; Campbell et al., 1996; Hercule
et al., 2007).
Recently, RBCs (~3 kg in human body) have been
implicated to serve as a reservoir for epoxide fatty acids,
in particular CYP-derived EETs, which on release may act
in a vasoregulatory capacity (Jiang et al., 2010; Jiang
et al., 2011). Furthermore, sEH in the RBC and the
increase in EETs resulting from its pharmacological inhi-
bition presumably contributes to a greater degree on
regional blood flows than sEH inhibition localized in the
arterial wall (Yu et al., 2004; Jiang et al., 2011). Both cis-
and trans-EETs are stored in phospholipids and in RBCs.
The greater vasodilator potency of trans- vs. cis-EETs may
contribute to the antihypertensive effects of sEH inhibi-
tors in rats (Jiang et al., 2011). However, it is unknown
whether physical exercise affects the RBC epoxy fatty acid
status. We tested the hypothesis that acute, maximal
physical exercise might affect RBC epoxy fatty acids. Max-
imal treadmill Bruce test was used to ensure sufficient
and robust metabolic and hemodynamic response in
healthy individuals. RBC lipidomics was performed using
liquid chromatography-mass spectrometry in tandem
(LC–MS/MS).
Methods
Prior to participation in the study, six healthy volunteers
(5 male and 1 female; age 38  15 years; body mass
index 27.9  6.6 kg/m2) signed informed consent forms
which outlined the procedures to be taken and the possi-
ble risks involved. The study was approved by the Charite
University Medicine institutional review board on the use
of humans in research. All subjects were non-trained and
not taking medications. Recruitment was primarily via
person-to-person interview. Following a routine physical
examination at baseline levels each subject underwent a
maximal treadmill Bruce test, which is recommended by
guidelines for ergometry of the German Society of Cardi-
ology (Bruce et al., 1973; Trappe and Lollgen, 2000). The
test was preceded by 2 x 3 min warm up periods (stages
1 and 2 of the Bruce protocol) during which treadmill
speed was maintained at a constant speed of 2.7 km/h
and at zero or 5 per cent grade (Table 1) (Gollasch et al.,
2019). Treadmill speed and grade were then increased at
three min intervals. The test was terminated when the
subjects informed the investigator that they could no
longer proceed. Workload was assessed in metabolic
equivalents (METs) (Table 1).
Heart rates were monitored continuously by heart-rate
monitor worn around the subject’s torso (Polar T31,
Polar Electro, Kempele, Finland). Arterial pressure was
measured via a sphygmomanometer (Critikon, Inc., John-
son & Johnson, New Jersey, USA), which comprised an
inflatable (Riva-Rocci) cuff placed around the upper arm.
Venous blood was collected from a catheter placed in a
contralateral forearm vein (i.e., the antecubital vein) of
each subject in the sitting position prior to the exercise
test (10 mins, P1), after termination of the test (exhaus-
tion, P3), and 10 min after the end of the running test
(recovery period, P4) (Fig. 2). An additional blood sam-
ple was collected in each subject during running when the
heart rate reached 150 beats per minute (P2). All samples
were analyzed for total and free RBC epoxide lipid media-
tor status. RBCs were separated from EDTA blood by
centrifugation and metabolites were determined by liquid
chromatography tandem mass (LC–MS/MS) spectrometry
as described in Fischer et al., (2014). Serum lactate was
determined in blood samples obtained from ear lobe at
rest and at maximal workload (Fig. 2).
Descriptive statistics were calculated and variables were
examined for meeting assumptions of normal distribution
without skewness and kurtosis. In order to determine sta-
tistical significance between the trials at the various time
intervals, one-way repeated measures analysis of variance
(ANOVA) was conducted and the 0.05 level of signifi-
cance (P) was chosen. The analysis included Mauchly’s
test of sphericity followed by applying the test of within-
subjects’ effects with Greenhouse–Geisser correction,
which is used for repeated-measures ANOVA when the
assumption of sphericity is violated. When significant dif-
ferences were found, Tukey’s honestly significant differ-
ence post hoc test was used for pairwise comparisons.
The nonparametric test (distribution-free) Friedman’s test
was used when the normal distribution was violated.
Planned hypotheses (one-tailed or two-tailed paired t-
tests as appropriate) were tested to follow up the initial
ANOVA findings. All data are presented as mean  SD.
All statistical analyses were performed using SPSS Statis-
tics software (IBM Corporation, Armonk, NY, USA) or
Table 1. Bruce protocol and estimated metabolic equivalents of
task (METs).
Stages
Duration
(in min)
Grade
(in %)
Speed
(in km/h)
Speed
(in MPH) METs
1 3 0 2.7 1.7 Warm up
2 3 5 2.7 1.7 Warm up
3 3 10 2.7 1.7 5
4 3 12 4.0 2.5 7
5 3 14 5.4 3.4 10
6 3 16 6.7 4.2 13
7 3 18 8.0 5.0 15
8 3 20 8.8 5.5 18
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All-Therapy statistics beta (AICBT Ltd, Vancouver,
Canada).
Results
Hemodynamic and metabolic response
Exercise significantly increased heart rate and systolic, but
not diastolic blood pressure (Table 2). Data prior to the
exercise test (10 mins, P1), after termination of the test
(exhaustion, P3), and 10 min after the end of the running
test (recovery period, P4) are shown in Figure 2. An addi-
tional blood sample (P2) was obtained throughout exer-
cise when the heart rate reached 150 beats per minute.
After exercise, heart rate and systolic blood pressure
returned to resting levels (P1) in the recovery period (P4)
(Table 2, P > 0.05, Tukey’s post hoc test) (Gollasch et al.,
2019). All participants terminated exercise at a maximal
workload of 13.50  1.97 METs (Bruce stage,
6.33  0.82). Exercise increased lactate concentrations
from 1.3  0.3 (P1) to 9.5  2.1 mmol/L (P3)
(P < 0.0001, t-test).
Fatty acid-derived cis-mediators
Since the impact of acute exercise on individual RBC
epoxide fatty acid status is unknown, we initially used an
explorative statistical approach and measured the total
cis-metabolites in RBCs at: baseline (rest, P1), the time
when heart rate reached 150 beats per min (P2), exhaus-
tion (P3), and recovery (P4) (Table 3). Our ANOVA
analysis indicated differences in the total levels of epoxy-
octadecenoic acids (9,10-EpOME, 12,13-EpOME),
epoxyeicosatrienoic acids (5,6-EET, 11,12-EET, 14,15-
EET), and epoxydocosapentaenoic acids (16,17-EDP,
19,20-EDP) (Table 3). However, we did not observe dif-
ferences in the total levels of epoxyeicosatetraenoic acids
(5,6-EEQ, 8,9-EEQ, 11,12-EEQ, 14,15-EEQ), 8,9-EET,
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Figure 2. Following abbreviations are: HF, heart rate; BP, blood pressure; RBC, red blood cell; epoxy, epoxide fatty acids; METs, metabolic
equivalents of task.
Table 2. Effects of exercise on hemodynamics (means  SD, n = 6).
Parameter
Time point 1,
P1 (rest)
Time point 2,
P2 (HF 150)
Time point 3,
P3 (exhaustion)
Time point 4,
P4 (recovery)
Greenhouse–Geisser,
P value
Heart rate (beats per min) 71  10 150 185  6 94  11 <0.001
Systolic arterial blood pressure (mm Hg) 135.3  9.1 n.d. 190.3  16.6 127.5  13.1 <0.001
Diastolic arterial blood pressure 81.2  14.4 n.d. 90.7  16.4 76.3  10.2 0.097
n.d., not determined
2019 | Vol. 7 | Iss. 22 | e14275
Page 4
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Exercise and RBC Epoxy-Metabolites B. Gollasch et al.
Table 3. Total cis-metabolites in erythrocytes in response to exhaustive exercise (n = 6).
Metabolite (ng/g)
Time point 1
(rest), P1
Time point 2
(HF 150), P2
Time point 3
(exhaustion), P3
Time point 4
(recovery), P4
Greenhouse–Geisser,
P value
13-HODE 1258.0  382.54 1124.22  214.01 1296.36  330.21 1329.40  329.97 0.550
9,10-EpOME 101.62  11.50 122.80  13.14 125.09  16.78 128.38  17.81 Friedman
P = 0.002
12,13-EpOME 99.25  12.74 119.61  15.71 125.09  18.65 129.29  22.75 0.001
9,10-DiHOME 3.34  1.50 6.30  5.59 3.48  1.00 4.68  2.99 Friedman
P = 0.108
12,13-DiHOME 7.10  2.80 11.06  7.50 7.68  2.06 9.97  5.00 Friedman
P = 0.056
5,6-EET 54.75  6.93 64.05  5.61 61.67  9.06 63.80  8.11 0.021
8,9-EET 70.70  11.08 77.28  7.25 75.20  12.31 79.33  11.92 0.247
11,12-EET 71.69  9.72 83.11  9.75 80.74  13.51 85.32  12.54 0.039
14,15-EET 79.97  13.23 93.61  12.03 89.06  14.96 94.77  14.49 0.038
5,6-DHET 4.67  0.46 5.19  0.51 4.77  0.15 5.14  0.63 0.191
8,9-DHET 3.29  0.44 3.74  0.37 3.57  0.46 3.74  0.51 0.202
11,12-DHET 1.97  0.36 2.28  0.25 2.11  0.21 2.18  0.30 0.279
14,15-DHET 1.68  0.32 1.75  0.15 1.71  0.13 1.79  0.24 0.790
5,6-EEQ 1.14  0.63 1.23  0.58 1.09  0.46 1.17  0.60 0.10
8,9-EEQ 3.00  1.15 3.03  0.75 3.26  0.93 3.22  1.11 0.673
11,12-EEQ 2.38  0.78 2.48  0.65 2.24  0.59 2.57  0.82 0.433
14,15-EEQ 2.67  0.86 2.75  0.62 2.87  0.66 2.91  0.80 0.583
17,18-EEQ 3.62  0.94 3.69  0.98 3.62  0.78 3.64  1.02 0.988
5,6-DiHETE 0.78  0.44 0.45  0.40 0.72  0.61 0.16  0.38 0.090
8,9-DiHETE 0 0 0 0 n/a
11,12-DiHETE 0 0 0 0 n/a
14,15-DiHETE 0 0 0 0 n/a
17,18-DiHETE 3.49  1.33 3.95  0.99 4.50  0.83 3.82  0.64 0.153
7,8-EDP 29.72  5.06 33.36  6.52 31.70  7.26 33.30  7.33 0.175
10,11-EDP 42.64  7.31 48.27  10.14 45.13  9.83 48.17  11.21 0.122
13,14-EDP 21.34  4.31 25.22  6.70 23.56  5.30 25.42  6.01 0.096
16,17-EDP 27.04  3.95 32.08  6.97 30.73  6.33 32.70  7.22 0.021
19,20-EDP 26.50  4.83 30.84  7.20 29.00  6.00 31.32  6.45 0.015
7,8-DiHDPA 0.79  0.31 0.78  0.27 0.83  0.19 0.98  0.19 0.157
10,11-DiHDPA 0.17  0.10 0.18  0.10 0.19  0.11 0.18  0.09 0.671
13,14-DiHDPA 0.23  0.18 0.24  0.19 0.22  0.17 0.23  0.18 Friedman
P = 0.800
16,17-DiHDPA 0.25  0.30 0.27  0.31 0.38  0.31 0.34  0.29 0.501
19,20-DiHDPA 0.05  0.13 0.07  0.16 0.07  0.16 0.00  0.00 Friedman
P = 1.000
5-HETE 214.23  135.63 143.99  39.23 189.26  66.21 190.40  44.62 0.382
8-HETE 96.31  52.88 72.09  17.92 88.21  24.46 89.10  18.74 0.428
9-HETE 116.82  54.61 91.29  21.93 106.86  30.34 113.23  22.46 0.430
11-HETE 249.20  130.33 181.35  40.77 225.53  59.37 248.41  56.47 0.353
12-HETE 118.25  54.03 90.30  20.67 114.03  37.09 112.58  22.98 0.384
15-HETE 114.64  70.53 81.36  22.06 106.69  34.94 105.07  28.06 0.426
19-HETE 0 0 0 0 n/a
20-HETE 0 0 0 0 n/a
5-HEPE 8.61  5.43 5.92  1.53 7.59  2.24 8.09  2.18 0.364
8-HEPE 3.25  1.95 2.18  0.33 2.98  0.98 2.86  0.98 0.365
9-HEPE 4.70  2.52 3.81  1.29 4.54  1.27 4.53  1.53 0.449
12-HEPE 5.09  2.33 4.17  1.29 4.75  1.70 5.14  1.92 0.508
15-HEPE 4.93  2.27 4.14  0.66 4.29  1.02 4.48  0.88 Friedman
P = 0.772
18-HEPE 15.62  8.93 12.08  4.44 13.69  3.72 14.21  3.70 0.496
(Continued)
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10,11-EDP, 13,14-EDP, hydroxyeicosapentaenoic acids (5-
HEPE, 8-HEPE, 9-HEPE, 12-HEPE, 15-HEPE, 18-HEPE)
and hydroxyeicosatetraenoic acids (5-HETE, 8-HETE, 9-
HETE, 11-HETE, 12-HETE, 15-HETE). We identified no
differences in hydroxydocosahexaenoic acids (4-HDHA,
7-HDHA, 8-HDHA, 10-HDHA, 11-HDHA, 13-HDHA,
14-HDHA, 16-HDHA, 17-HDHA, 20-HDHA) and 13-
HODE levels. Of note, RBCs did not contain relevant
levels of 19-HEPE, 20-HEPE, 19-HETE, and 20-HETE
(detection threshold, <0.05 ng/g) (Table 3). The data
demonstrate an accumulation of total 5,6-EET, 11,12-
EET, 14,15-EET, 16,17-EDP, 19,20-EDP 9,10-EpOME,
and 12,13-EpOME concentrations in RBCs at exhaustion
(for all P < 0.05, t-tests), which are potent vasodilators
(Siegfried et al., 1990; Jiang et al., 2010; Jiang et al., 2011;
Morin et al., 2011). Accumulation of total 5,6-EET,
11,12-EET, 14,15-EET, 16,17-EDP, 19,20-EDP, 9,10-
EpOME and 12,13-EpOME levels in RBCs persisted in
the recovery period (10 min) (P < 0.05, t-tests). The data
suggest that exercise leads to an accumulation of various
CYP (i.e. cis) epoxy-metabolites into membrane-bound
compartments of RBCs under exhaustive exercise or in
ischemia in healthy individuals, which on release may act
in a vasoregulatory capacity.
To provide possible insights into the nature of this
accumulation, we measured free epoxy and hydroxy
metabolites in RBCs. We detected significant levels of free
13-HODE, 9,10-EpOME, 12,13-EpOME, 9,10-DiHOME,
12,13-DiHOME, 14,15-DHET, 12-HETE, 12-HEPE, 4-
HDHA, 14-HDHA, and 16-HDHA in RBCs (i.e., above
the detection level, cf. methods), although no changes
occurred in response to exercise (Table 4). Exercise did not
induce significant levels of the majority of free fatty acid
metabolites and PGs, including 5,6-EET, 8,9-EET, 11,12-
EET, 14,15-EET, 5,6-DHET, 8,9-DHET, 5,6-EEQ, 8,9-EEQ,
11,12-EEQ, 14,15-EEQ, 17,18-EEQ, 8,9-DiHETE, 11,12-
DiHETE, 14,15-DiHETE, 17,18-DiHETE, 7,8-EDP, 10,11-
EDP, 13,14-EDP, 16,17-EDP, 19,20-EDP, 7,8-DiHDPA,
10,11-DiHDPA, 13,14-DiHDPA, 16,17-DiHDPA, 19,20-
DiHDPA, LTB4, LXA4, 5-HETE, 8-HETE, 9-HETE, 11-
HETE, 15-HETE, 19-HETE, 20-HETE, 5-HEPE, 8-HEPE,
15-HEPE, 18-HEPE, 19-HEPE, 20-HEPE, 10,17-DiHDHA,
7-HDHA, 8-HDHA, 10-HDHA, 11-HDHA, 13-HDHA, 17-
HDHA, 20-HDHA, 21-HDHA, 22-HDHA, PGH2, PGE2,
15-keto-PGE2, 13,14-dihydro-15-keto-PGE2, Bicyclo PGE2
(a), Bicyclo PGE2 (b), PGD2, PGI2, 15-deoxy-delta 12,14-
PGI2, PGF2a, TXB2, 11-dehydro TXB2, 6-keto-PGF1a,
PGE3, TXB3, 11-dehydro TXB3, d17-6-keto-PGF1a
(Table 4; detection level of 0.05 ng/g, each). The data
suggest that maximal exercise does not result in accumu-
lation of free epoxy-metabolites and other fatty acid meta-
bolites in RBCs for their uptake into membrane-bound
compartments.
Diols
The main pathway of EET, EpOME, EEQ, and EDP meta-
bolism is conversion to DHETs, DiHOMEs, dihydroxye-
icosatetraenoic acids (DiHETEs), and dihydroxydoco-
sapentaenoic acids (DiHDPAs) by the sEH, respectively
(Fig. 1) (Spector et al., 2004). Since acute exercise might
have caused EET, EpOME, EEQ, and EDP accumulation
rapidly degraded to their diols, we analyzed their individ-
ual levels (Table 3) and the sums of the individual break-
down products and their respective diols (Table 5). Exer-
cise did not change the levels of 9,10-DiHOME, 12,13-
DiHOME, 5,6-DHET, 8,9-DHET, 11,12-DHET, 14,15-
DHET, 5,6-DiHETE, 17,18-DiHETE, 7,8-DiHDPA, 10,11-
Table 3. Continued.
Metabolite (ng/g)
Time point 1
(rest), P1
Time point 2
(HF 150), P2
Time point 3
(exhaustion), P3
Time point 4
(recovery), P4
Greenhouse–Geisser,
P value
19-HEPE 0 0 0 0 n/a
20-HEPE 0 0 0 0 n/a
10,17-DiHDHA 0 0 0 0 n/a
4-HDHA 116.85  52.93 81.07  11.71 111.98  31.57 111.76  27.96 0.343
7-HDHA 28.35  8.70 23.03  3.32 27.20  5.92 29.38  6.92 0.358
8-HDHA 48.33  12.77 36.50  5.34 47.08  12.37 49.39  12.78 0.249
10-HDHA 34.29  12.83 25.41  3.45 32.34  8.87 34.11  9.39 0.358
11-HDHA 29.71  10.19 23.66  4.09 30.18  9.39 30.88  8.57 0.448
13-HDHA 48.34  12.09 39.15  5.08 48.70  13.74 49.00  11.68 0.350
14-HDHA 60.42  14.68 49.70  7.96 61.95  18.41 62.66  17.61 0.404
16-HDHA 44.51  11.95 35.68  4.31 43.14  11.49 44.97  11.68 0.382
17-HDHA 75.87  22.48 58.99  6.36 79.46  17.22 76.49  21.83 0.283
20-HDHA 65.09  21.77 47.56  6.85 63.43  16.05 16.05  17.91 0.285
21-HDHA 0 0 0 0 n/a
22-HDHA 0 0 0 0 n/a
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Table 4. Free cis-metabolites in red blood cells (RBCs) in response to exhaustive exercise (n = 6).
Metabolite (ng/g)
Time point 1
(rest), P1
Time point 2
(HF 150), P2
Time point 3
(exhaustion), P3
Time point 4
(recovery), P4
Greenhouse–Geisser,
P value
13-HODE 63.81  27.94 58.56  3.82 53.29  5.15 53.36  8.77 0.474
9,10-EpOME 9.05  1.17 1.17  1.23 8.31  0.82 8.34  1.17 0.377
12,13-EpOME 9.17  1.39 9.70  0.95 8.97  0.92 9.06  0.93 0.612
9,10-DiHOME 1.87  0.17 2.12  0.43 1.90  0.23 1.85  0.22 Friedman
P = 0.512
12,13-DiHOME 4.18  0.43 4.63  0.51 4.09  0.44 4.46  0.18 0.076
5,6-EET 0 0 0 0 n/a
8,9-EET 0 0 0 0 n/a
11,12-EET 0 0 0 0 n/a
14,15-EET 0 0 0 0 n/a
5,6-DHET 0 0 0 0 n/a
8,9-DHET 0 0 0 0 n/a
14,15-DHET 0.81  0.40 0.85  0.43 1.04  0.05 0.84  0.41 Friedman
P = 0.398
5,6-EEQ 0 0 0 0 n/a
8,9-EEQ 0 0 0 0 n/a
11,12-EEQ 0 0 0 0 n/a
14,15-EEQ 0 0 0 0 n/a
17,18-EEQ 0 0 0 0 n/a
8,9-DiHETE 0 0 0 0 n/a
11,12-DiHETE 0 0 0 0 n/a
14,15-DiHETE 0 0 0 0 n/a
17,18-DiHETE 0 0 0 0 n/a
7,8-EDP 0.05  0.14 0 0 0 n/a
10,11-EDP 0 0 0 0 n/a
13,14-EDP 0 0 0 0 n/a
16,17-EDP 0 0 0 0 n/a
19,20-EDP 0 0 0 0 n/a
7,8-DiHDPA 0 0 0 0 n/a
10,11-DiHDPA 0 0 0 0 n/a
13,14-DiHDPA 0 0 0 0 n/a
16,17-DiHDPA 0 0 0 0 n/a
19,20-DiHDPA 0 0 0 0 n/a
LTB4 0 0 0 0 n/a
LXA4 0 0 0 0 n/a
5-HETE 0 0 0 0 n/a
8-HETE 0 0 0 0 n/a
9-HETE 0 0 0 0 n/a
11-HETE 0 0 0 0 n/a
12-HETE 10.25  2.84 12.26  4.22 14.83  7.32 13.77  6.74 0.278
15-HETE 0 0 0 0 n/a
19-HETE 0 0 0 0 n/a
20-HETE 0 0 0 0 n/a
5-HEPE 0 0 0 0 n/a
8-HEPE 0 0 0 0 n/a
12-HEPE 1.34  0.58 1.74  0.78 1.88  1.20 1.91  1.02 Friedman
P = 0.073
15-HEPE 0 0 0 0 n/a
18-HEPE 0 0 0 0 n/a
19-HEPE 0 0 0 0 n/a
20-HEPE 0 0 0 0 n/a
10,17-DiHDHA 0 0 0 0 n/a
4-HDHA 2.82  1.04 3.12  1.03 2.83  0.75 2.87  0.67 0.488
(Continued)
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DiHDPA, 13,14-DiHDPA, 16,17-DiHDPA, 19,20-
DiHDPA (Table 3), but increased the levels 9,10-EpOME,
12,13-EpOME, 5,6-EET, 11,12-EET, 14,15-EET, 16,17-
EDP, and 19,20-EDP plus their respective diols (Table 5).
Diol/epoxide ratios
We next calculated diol/epoxide ratios in RBCs and ana-
lyzed their changes in response to exhaustive exercise and
post exercise (Table 6). Our ANOVA analysis revealed no
alterations in ratios for each substrate class in RBCs in vivo
during and post exercise. Similar results were found for the
individual metabolites (Table 7). Furthermore, we detected
that the four classes of epoxy-metabolites are unequally
hydrolyzed to appear in the RBCs (Greenhouse-Geisser, P1,
P = 0.001). Notably, we found that EEQs are preferentially
metabolized into their diols (ratio DiHETE/EEQs at P1,
0.356  0.100) compared to EpOMEs, EETs and EDPs (ra-
tios diols/epoxy-metabolites at P1, 0.051  0.013,
0.043  0.007, 0.009  0.004, respectively) (Table 6). The
following order of ratios was identified: DiHETEs/
EEQs> DHETs/EETs = DiHOMEs/EpOMEs> DiHDPA/
EDPs in RBCs (paired t-tests, one-tailed, Bonferroni cor-
rection). In our earlier studies, we observed similar results
for plasma diols/epoxides in plasma (Gollasch et al., 2019).
The ratios did not change in response to exercise (Table 6).
This state-of-affairs was also the case for to the individual
diol/epoxide metabolites in RBCs (Table 7). In our previ-
ous studies, we obtained similar results for plasma diols/
epoxides in plasma (Gollasch et al., 2019). The observed
findings are unlikely to result from changes in the levels of
arachidonic, linoleic acid, docosahexanoic, or eicosapen-
taenoic acid (Fig. 1) as we previously found that acute,
maximal exercise is insufficient to change their levels (Gol-
lasch et al., 2019).
Together the results indicate that differences in the
total RBC levels of 9,10-EpOME, 12,13-EpOME, 5,6-EET,
11,12-EET, 14,15-EET), 16,17-EDP, 19,20-EDP occur
from increased production and accumulation, rather than
altered sEH activity during acute, maximal exercise. Since
inhibitors of sEH are in clinical development, these find-
ings could be important for patients.
Table 4. Continued.
Metabolite (ng/g)
Time point 1
(rest), P1
Time point 2
(HF 150), P2
Time point 3
(exhaustion), P3
Time point 4
(recovery), P4
Greenhouse–Geisser,
P value
7-HDHA 0 0 0 0 n/a
8-HDHA 0 0 0 0 n/a
10-HDHA 0 0 0 0 n/a
11-HDHA 0 0 0 0 n/a
13-HDHA 0 0 0 0 n/a
14-HDHA 2.35  1.44 2.16  1.19 2.16  0.97 2.77  1.48 0.341
16-HDHA 0.13  0.21 0.29  0.37 0.24  0.26 0.18  0.21 Friedman
P = 0.446
17-HDHA 0 0 0 0 n/a
20-HDHA 0 0 0 0 n/a
21-HDHA 0 0 0 0 n/a
22-HDHA 0 0 0 0 n/a
PGH2 0 0 0 0 n/a
PGE2 0 0 0 0 n/a
15-keto-PGE2 0 0 0 0 n/a
13,14-dihydro-15-keto-PGE2 0 0 0 0 n/a
Bicyclo PGE2 (a) 0 0 0 0 n/a
Bicyclo PGE2 (b) 0 0 0 0 n/a
PGD2 0 0 0 0 n/a
PGI2 0 0 0 0 n/a
15-deoxy-delta 12,14-PGI2 0 0 0 0 n/a
PGF2a 0 0 0 0 n/a
TXB2 0 0 0 0 n/a
11-dehydro TXB2 0 0 0 0 n/a
6-keto-PGF1a 0 0 0 0 n/a
PGE3 0 0 0 0 n/a
TXB3 0 0 0 0 n/a
11-dehydro TXB3 0 0 0 0 n/a
d17-6-keto-PGF1a 0 0 0 0 n/a
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Trans-epoxides
Trans-EETs are stored in phospholipids and in RBCs in
the circulation, and have been proposed to contribute to
the antihypertensive effects of sEH inhibitors in rats
(Jiang et al., 2011). We measured trans-epoxy fatty acids
in RBCs. We observed that trans-EETs, trans-EEQs, and
trans-EDPs are stored at significant levels in human RBCs
Table 5. Concentrations of individual total cis-epoxides plus their respective diols in erythrocytes in response to exhaustive exercise (n = 6).
Epoxides or Diols (ng/g)
Time point 1
(rest), P1
Time point 2
(HF 150), P2
Time point 3
(exhaustion), P3
Time point 4
(recovery), P4
Greenhouse–Geisser,
P value
9,10-EpOME+9,10-DiHOME 104.97  12.95 129.09  15.44 128.57  17.62 133.06  18.67 <0.001
12,13-EpOME+12,13-DiHOME 106.35  15.49 130.68  19.66 132.77  20.26 139.26  26.13 <0.001
5,6-EET+5,6-DHET 59.42  6.92 69.24  5.40 66.45  9.00 68.94  8.52 0.012
8,9-EET+8,9-DHET 73.99  11.02 81.03  7.10 78.78  12.05 83.07  11.91 0.217
11,12 EET+11,12-DHET 73.68  9.71 85.39  9.65 82.85  13.42 87.50  12.57 0.035
14,15-EET+14,15-DHET 81.65  13.31 95.37  12.07 90.76  14.88 96.56  14.54 0.036
5,6-EEQ+5,6-DiHETE 1.92  0.84 1.69  0.71 1.82  0.91 1.33  0.56 0.376
8,9-EEQ+8,9-DiHETE 3.00  1.15 3.04  0.75 3.26  0.94 3.22  1.11 0.673
11,12-EEQ+11,12-DiHETE 2.39  0.78 2.49  0.64 2.24  0.59 2.57  0.83 0.435
14,15-EEQ+14,15-DiHETE 2.67  0.86 2.75  0.62 2.87  0.66 2.91  0.80 0.589
17,18-EEQ+17,18-DiHETE 7.11  1.80 7.64  0.88 8.13  1.18 7.46  1.54 0.174
7,8-EDP+7,8-DiHDPA 30.52  5.35 34.15  6.69 32.53  7.36 34.28  7.36 0.170
10,11-EDP+10,11-DiHDPA 42.81  7.39 48.46  10.19 45.32  9.89 48.35  11.27 0.120
13,14-EDP+13,14-DiHDPA 21.57  4.44 25.46  6.85 23.78  5.47 25.65  6.19 0.096
16,17-EDP+16,17-DiHDPA 27.29  4.07 32.36  7.06 31.12  6.61 33.05  7.51 0.020
19,20-EDP+19,20-DiHDPA 26.55  4.84 30.90  7.20 29.07  6.10 31.32  6.45 0.016
Table 6. Ratios estimated using total concentrations of cis-epoxides and diols in erythrocytes in response to exhaustive exercise (n = 6).
Epoxides or Diols (ng/g) or Ratios
Time point 1
(rest), P1
Time point 2
(HF 150), P2
Time point 3
(exhaustion), P3
Time point 4
(recovery), P4
Greenhouse–
Geisser,
P value
9,10-EpOME+12,13-EpOME 200.87  24.05 242.41  28.57 250.19  35.01 257.68  40.38 0.001
9,10-DiHOME+12,13-DiHOME 10.44  4.29 17.36  13.09 11.15  3.02 14.65  7.90 0.255
Ratio (9,10-DiHOME+12,13-DiHOME)/(9,10-
EpOME+12,13-EpOME)
0.0507  0.0133 0.0707  0.0534 0.0443  0.0085 0.0561  0.0283 0.335
5,6-EET+8,9-EET+11,12 EET+14,15-EET 277.11  40.02 318.06  33.40 306.68  49.10 323.22  46.52 0.058
5,6-DHET+8,9-DHET+11,12-DHET+14,15-DHET 11.63  1.39 12.97  1.07 12.16  0.76 12.85  1.47 0.248
Ratio(5,6-DHET+8,9-DHET+11,12-DHET+14,15-
DHET)/(5,6-EET+8,9-EET+11,12 EET+14,15-EET)
0.0427  0.0076 0.0413  0.0062 0.0409  0.0094 0.0404  0.0064 0.763
5,6-EEQ+8,9-EEQ+11,12-EEQ+14,15-
EEQ+17,18-EEQ
12.81  4.28 13.19  3.43 13.09  3.18 13.51  4.22 0.814
5,6-DiHETE+8,9-DiHETE+11,12-DiHETE+14,15-
DiHETE+17,18-DiHETE
4.28  1.15 4.41  0.76 5.22  0.63 3.98  0.48 0.091
Ratio(5,6-DiHETE+8,9-DiHETE+14,15-
DiHETE+17,18-DiHETE)/(5,6-EEQ+8,9-
EEQ+11,12-EEQ+14,15-EEQ+17,18-EEQ)
0.3566  0.1004 0.3622  0.1344 0.4199  0.1104 0.3165  0.1001 0.071
7,8-EDP+10,11-EDP+13,14-EDP+16,17-
EDP+19,20-EDP
147.24  24.88 169.77  36.84 160.14  34.18 170.91  37.80 0.057
7,8-DiHDPA+10,11-DiHDPA+13,14-
DiHDPA+16,17-DiHDPA+19,20-DiHDPA
1.50  0.77 1.55  0.63 1.68  0.78 1.75  0.62 0.331
Ratio(7,8-DiHDPA+10,11-DiHDPA+13,14-
DiHDPA+16,17-DiHDPA+19,20-DiHDPA)/(7,8-
EDP+10,11-EDP+13,14-EDP+16,17-EDP+19,20-
EDP)
0.0098  0.0042 0.0090  0.0029 0.0101  0.0032 0.0101  0.0024 0.686
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(Table 8). The total concentrations of these trans-metabo-
lites are ~ 1.5-2-fold lower than the concentrations of
their respective cis-metabolites (cf. Table 3; Table 9). No
changes occurred in the trans-metabolites in response to
exercise (Table 8). Similar results were observed for free
trans-EETs, trans-EEQs and trans-EDPs (Table 10). Our
results suggest that these RBC trans-epoxides presumably
do not contribute to the metabolic and hemodynamic
response in acute, maximal exercise.
Discussion
To the best of our knowledge, we conducted the first
study on the impact of acute exercise on eicosanoids in
RBCs. Epoxy-metabolite and hydroxy RBC profiling was
performed on venous blood taken form healthy individu-
als. The volunteers were subjected to maximal treadmill
exercise using the standard Bruce protocol. This protocol
induces strong and robust hemodynamic and metabolic
changes (Bruce et al., 1973; Trappe and Lollgen, 2000).
We confirmed our hypothesis that individual RBC EETs
and EDPs are influenced by acute, exhaustive exercise,
but trans-epoxy and LOX metabolites are not. These find-
ings indicate involvement of CYP. These changes were
associated with heart rate, systolic blood pressure, and
serum lactate increases, which occurred at 13.5 METs.
Our results indicate that RBC could represent a reservoir
for PUFA CYP epoxy-metabolites, which on release may
Table 7. Ratios estimated using individual concentrations of total cis-epoxides and their diols in erythrocytes in response to exhaustive exercise
(n = 6).
Ratios
Time point 1
(rest), P1
Time point 2
(HF 150), P2
Time point 3
(exhaustion), P3
Time point 4
(recovery), P4
Greenhouse–Geisser,
P value
9,10-DiHOME/9,10-EpOME 0.0320  0.0097 0.0508  0.0460 0.0275  0.0052 0.0364  0.0238 0.319
12,13-DiHOME/12,13-EpOME 0.0698  0.0169 0.0912  0.0606 0.0610  0.0117 0.0755  0.0322 0.345
5,6-DHET/5,6-EET 0.0865  0.0130 0.0818  0.0123 0.0791  0.0146 0.0810  0.0088 0.592
8,9-DHET/8,9-EET 0.0476  0.0098 0.0490  0.0075 0.0491  0.0129 0.0482  0.0101 0.911
11,12-DHET/11,12-EET 0.0282  0.0065 0.0279  0.0052 0.0270  0.0071 0.0261  0.0050 0.618
14,15-DHET/14,15-EET 0.0215  0.0045 0.0190  0.0027 0.0199  0.0053 0.0192  0.0035 0.503
5,6-DiHETE/5,6-EEQ 0.8995  0.6214 0.4716  0.5161 0.6989  0.6652 0.2429  0.5950 0.088
8,9-DiHETE/8,9-EEQ 0 0 0 0 n/a
11,12-DiHETE/11,12- EEQ 0 0 0 0 n/a
14,15-DiHETE/14,15-EEQ 0 0 0 0 n/a
17,18-DiHETE/17,18-EEQ 0.9919  0.3072 1.1739  0.4890 1.2901  0.3398 1.100  0.2536 0.286
7,8-DiHDPA/7,8-EDP 0.0261  0.0067 0.0235  0.0063 0.0267  0.0058 0.0309  0.0105 0.270
10,11-DiHDPA/10,11-EDP 0.0039  0.0020 0.0038  0.0021 0.0041  0.0023 0.0038  0.0021 0.851
13,14-DiHDPA/13,14-EDP 0.0101  0.0082 0.0085  0.0067 0.0081  0.0063 0.0081  0.0063 0.169
16,17-DiHDPA/16,17-EDP 0.0089  0.0103 0.0083  0.0098 0.0110  0.0089 0.0091  0.0077 0.734
19,20-DiHDPA/19,20-EDP 0.0019  0.0047 0.0022  0.0054 0.0019  0.0046 0 0.606
Table 8. Total trans-metabolites in erythrocytes in response to exhaustive exercise (n = 6).
Metabolite (ng/g)
Time point 1
(rest),P1
Time point 2
(HF 150),P2
Time point 3
(exhaustion),P3
Time point 4
(recovery),P4
Greenhouse–Geisser,
P value
5,6-EET trans 30.05  11.03 26.83  4.98 30.78  7.34 30.17  6.18 0.386
8,9-EET trans 44.41  13.64 39.18  7.17 45.11  10.86 48.67  8.84 0.280
11,12-EET trans 47.38  15.21 44.90  9.08 50.60  12.36 52.31  9.96 0.388
14,15-EET trans 39.00  12.52 36.16  6.14 41.68  9.19 43.40  7.57 0.296
8,9-EEQ trans 0 0 0 0 n/a
11,12-EEQ trans 0.99  0.32 1.05  0.30 1.05  0.22 1.04  0.18 0.887
14,15-EEQ trans 1.89  0.52 1.84  0.50 2.01  0.53 2.25  0.57 0.088
17,18-EEQtrans 2.40  0.57 2.43  0.53 2.42  0.73 2.43  0.54 0.99
7,8-EDP trans 11.59  1.22 10.00  1.55 11.73  2.25 12.44  2.79 0.160
10,11-EDP trans 33.23  5.52 30.44  5.02 34.73  7.43 36.68  8.70 0.242
13,14-EDP trans 14.23  1.62 13.66  2.26 15.46  3.26 16.17  4.13 0.267
16,17-EDP trans 17.03  2.06 15.16  2.17 17.77  4.20 17.98  4.73 0.207
19,20-EDP trans 13.72  1.94 12.28  1.96 14.09  3.29 15.15  4.17 0.249
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act in a vasoregulatory capacity to affect hemodynamics
in acute, maximal exercise.
EETs
RBCs have been implicated to serve as a reservoir for EETs
which on release may act in a vasoregulatory capacity (Jiang
et al., 2010; Jiang et al., 2011). In addition to serving as car-
riers of O2, RBCs regulate vascular resistance and the distri-
bution of microvascular perfusion by liberating ATP and
EETs upon exposure to a low O2 environment (Jiang et al.,
2010; Sprague, 2010). The release of EETs is activated by
ATP stimulation via P2X7 receptors coupled to ATP trans-
porters to amplify the circulatory response to ATP (Jiang
et al., 2007). RBCs are reservoirs of EETs. As a matter of
fact, RBC may serve as a primary source of plasma EETs,
which are esterified to the phospholipids of lipoproteins.
Levels of free EETs in plasma are reduced, namely in the
range of ~3% of circulating EETs (Jiang et al., 2010; Jiang
et al., 2011). RBC EETs are produced by direct oxidation of
arachidonic acid (AA) esterified to glycerophospholipids
and the monooxygenase-like activity of hemoglobin (Jiang
et al., 2010; Jiang et al., 2011; Jiang et al., 2012). On release,
EETs exert effects on vascular tone and blood pressure. In
addition, EETs produce pro-fibrinolysis and reduce inflam-
mation (Jiang et al., 2010; Jiang et al., 2011; Jiang et al.,
2012). An sEH is now recognized to regulate the RBC EET
levels by EET catabolism into DHETs ( Jiang et al., 2011).
Our results demonstrate that physical exercise affects the
RBC CYP epoxy-metabolite status, which could contribute
to the hemodynamic and metabolic response in acute,
exhausting exercise. In particular, we observed increases in
total concentrations of EETs (5,6-EET, 11,12-EET, 14,15-
EET) in RBCs, which are potent vasodilators (Jiang et al.,
2010; Sprague, 2010; Jiang et al., 2011). We did not observe
an increase in RBC DHETs levels. DHETs were initially
Table 9. Ratios of total cis-metabolites versus total trans-metabolites in erythrocytes (n = 6).
Metabolite (ng/g) Cis, Time point 1 (rest),P1 Trans, Time point 1 (rest),P1 Ratio (Cis/Trans)
5,6-EET 54.75  6.93 30.05  11.03 1.8
8,9-EET 70.70  11.08 44.41  13.64 1.6
11,12-EET 71.69  9.72 47.38  15.21 1.6
14,15-EET 79.97  13.23 39.00  12.52 2.1
11,12-EEQ 2.38  0.78 0.99  0.32 2.4
14,15-EEQ 2.67  0.86 1.89  0.52 1.4
17,18-EEQ 3.62  0.94 2.40  0.57 1.5
7,8-EDP 29.72  5.06 11.59  1.22 2.6
10,11-EDP 42.64  7.31 33.23  5.52 1.3
13,14-EDP 21.34  4.31 14.23  1.62 1.5
16,17-EDP 27.04  3.95 17.03  2.06 1.6
19,20-EDP 26.50  4.83 13.72  1.94 1.9
Table 10. Free trans-metabolites in blood plasma in response to exhaustive exercise (n = 6).
Metabolite (ng/ml)
Time point 1
(rest), P1
Time point 2
(HF 150), P2
Time point 3
(exhaustion), P3
Time point 4
(recovery), P4
Greenhouse–Geisser,
P value
5,6-EET trans 2.77  0.67 3.01  1.14 2.74  0.99 2.59  0.67 0.458
8,9-EET trans 4.43  1.18 4.95  1.55 4.44  1.35 4.15  1.17 0.296
11,12-EET trans 4.70  1.23 5.05  1.60 4.50  1.52 4.15  1.27 0.306
14,15-EET trans 3.81  0.97 4.05  1.32 3.69  1.14 3,53  1.16 0.461
8,9-EEQ trans 0.16  0.07 0.18  0.06 0.20  0.08 0.18  0.07 0.525
11,12-EEQ trans 0.33  0.08 0.30  0.13 0.32  0.08 0.27  0.10 0.444
14,15-EEQ trans 0.38  0.08 0.37  0.11 0.35  0.07 0.33  0.12 0.293
17,18-EEQtrans 0.45  0.09 0.46  0.14 0.45  0.14 0.41  0.12 0.539
7,8-EDP trans 1.15  0.22 1.30  0.48 1.18  0.43 1.05  0.21 0.328
10,11-EDP trans 3.36  0.65 3.66  1.47 3.35  1.34 2.92  0.58 0.347
13,14-EDP trans 1.37  0.58 1.42  0.51 1.28  0.42 1.26  0.21 0.531
16,17-EDP trans 1.29  0.35 1.35  0.56 1.16  0.51 1.06  0.27 0.138
19,20-EDP trans 1.34  0.33 1.49  0.55 1.30  0.54 1.22  0.29 0.403
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thought to be inactivation products of EETs. Nonetheless,
recent studies indicate that, like EETs, they produce vasodi-
lation (Hercule et al., 2009), possibly by activating BKCa
channels in vascular smooth muscle cells (Lu et al., 2001).
It is unknown whether RBCs are capable of liberating
DHETs upon exposure to a low O2 environment or ATP.
Our results indicate that short-term maximal exercise
affects the RBC reservoir for EETs, but not DHETs, which
on release may act in a vasoregulatory capacity to affect the
cardiovascular response.
Other PUFA metabolites
We observed increases in total concentrations of EDPs
(16,17-EDP, 19,20-EDP) and EpOMEs (9,10-EpOME and
12,13-EpOME) in RBCs during maximal exercise. 16,17-
EDP and 19,20-EDP are potent vasodilators in coronary,
pulmonary and mesenteric arteries and can lower blood
pressure and exhibit cardioprotection by preservation of
mitochondrial function (Morin et al., 2011; Schunck
et al., 2017). In contrast, 9,10-EpOME and 12,13-EpOME
are reported to represent vasoconstrictors in severe car-
diac ischemia (Siegfried et al., 1990; Dudda et al., 1996).
However, it is unknown whether RBCs are capable of lib-
erating EDPs or EpOMEs upon exposure to a low O2
environment or ATP. Our data indicate that both
metabolites are novel candidates for vasoactive substances
potentially released by RBCs upon maximal exercise to
affect hemodynamics in these conditions.
Furthermore, we observed that total levels of the CYP
metabolites 5,6-EEQ, 8,9-EEQ, 11,12-EEQ, 14,15-EEQ, 8,9-
EET, 10,11-EDP, and 13,14-EDP in RBCs were not influ-
enced by acute, exhaustive exercise. Similar effects were
observed for the LOX metabolites 5-HEPE, 8-HEPE, 9-
HEPE, 12-HEPE, 15-HEPE, 18-HEPE, 5-HETE, 8-HETE,
9-HETE, 11-HETE, 12-HETE, 15-HETE, 4-HDHA, 7-
HDHA, 8-HDHA, 10-HDHA, 11-HDHA, 13-HDHA, 14-
HDHA, 16-HDHA, 17-HDHA, 20-HDHA, and 13-HODE.
EEQs levels were low because the subjects did not receive
long chain n-3 fatty acid supplementation. The steadiness
of the HDHAs and HEPEs is of particular interest because
these DHA and EPA-derived metabolites are the precursors
of the D- and E-series of resolvins. Resolvins are members
of a novel class of lipid mediators that have highly potent
antiinflammatory and pro-resolution properties (Fischer
et al., 2014). Together, the data suggest that these PUFA
metabolites are unlikely to play a role in the cardiovascular
response caused by short-term exercise.
Diols
sEH converts EETs to DHETs, EpOMEs to DiHOMEs,
EEQs to DiHETEs, EDPs to DiHDPAs (Fig. 1) and
inhibition of sEH is a potential approach for enhancing
the biological activity of EETs (Spector and Kim, 2015).
However, presumably higher levels of EETs in blood and
tissue in vivo may have also detrimental cardiovascular
side effects, such as increased risk of ischemic stroke
(Gschwendtner et al., 2008) and higher recurrence of
atrial fibrillation after catheter ablation in humans (Wut-
zler et al., 2013), and reduced survival after cardiac arrest
and cardiopulmonary resuscitation in mice (Hutchens
et al., 2008). We cannot exclude that the higher levels of
EETs, EDPs, and EPOMEs in RBCs during maximal exer-
cise result from sEH inhibition. However, this is rather
unlikely since our ratio analyses argue against this possi-
bility. Furthermore, the DHET, DiHOME and DiHDPA
levels did also not vary during acute, exhausting exercise
in healthy volunteers. Finally, short-term exhaustive exer-
cise did not cause increased mobilization of individual
free epoxy-metabolites into RBC plasma. Nevertheless, the
effects of the erythro-DHETs, erythro-DiHOMEs, ery-
thro-DiHDPAs has yet to be integrated into a patho-
physiological context.
Epoxy-metabolites in the recovery period
Accumulation of total 5,6-EET, 11,12-EET, 14,15-EET,
16,17-EDP, 19,20-EDP, 9,10-EpOME, and 12,13-EpOME
levels in RBCs persisted in the recovery period (10 min).
The reason is unclear but may represent a phenomenon
similar to the recovery pulse sum, which becomes larger
when the loading intensity is above the long-term perfor-
mance limit. We suspect that levels of 5,6-EET, 11,12-
EET, 14,15-EET, 16,17-EDP, 19,20-EDP, 9,10-EpOME,
and 11,12-EpOME in RBCs will return to normal levels
after a longer resting time interval.
Exercise protocol considerations
The Bruce-protocol was used to ensure that all runners
were able to complete a similar highest intensity workload
concomitant with robust and significant increases in
hemodynamics without fatiguing. Our clinical data
(Table 2) show that the protocol caused the expected
hemodynamic and metabolic responses.
Limitations
Our treadmill testing was primarily developed to identify
ischemic heart disease; fortunately, none of our subjects
had this condition. Other exhaustive protocols might have
been better. Furthermore, the workload was increased in
large increments. Primarily the leg musculature was
stressed. We obtained venous blood samples and perhaps
a source closer to contracting muscle would have been
2019 | Vol. 7 | Iss. 22 | e14275
Page 12
ª 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Exercise and RBC Epoxy-Metabolites B. Gollasch et al.
more elucidative (Giordano et al., 2011). We studied
effects of maximal short-term exercise and therefore can-
not comment on endurance exercise. Possibly, different
results would have been obtained.
Conclusions
Our results suggest that maximal exercise affects the levels
of numerous CYP epoxy-metabolites in RBCs. We suggest
that RBCs are reservoir for EETs and possibly other epox-
ide fatty acids, which on release may act in a vasoregula-
tory capacity. More research is needed to delineate the
contribution of RBC epoxy-metabolites to cardiac perfor-
mance and skeletal-muscle blood flow in health and dis-
ease.
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